The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains
Open accessAbstract
From each of two AIDS patients with oropharyngeal candidiasis, five Candida albicans isolates from recurrent episodes of infection which became gradually resistant against fluconazole during antimycotic treatment were analyzed for molecular changes responsible for drug resistance. In both patients, a single C. albicans strain was responsible for the recurrent infections, but the CARE-2 fingerprint pattern of the isolates exhibited minor genetic alterations, indicating that microevolution of the strains took place during fluconazole therapy. In the isolates from patient 1, enhanced mRNA levels of the MDR1 gene, encoding a multiple drug resistance protein from the superfamily of major facilitators, and constitutive high expression of the ERG11 gene, coding for the drug target enzyme sterol 14alpha-demethylase, correlated with a stepwise development of fluconazole resistance. The resistant strains exhibited reduced accumulation of fluconazole and, for the last in the series, a slight increase in drug needed to inhibit sterol 14alpha-demethylation in vitro. In the isolates from patient 2, increased MDR1 mRNA levels and the change from heterozygosity to homozygosity for a mutant form of the ERG11 gene correlated with continuously decreased drug susceptibility. In this series, reduced drug accumulation and increased resistance in the target enzyme activity, sterol 14alpha-demethylase, were observed. These results demonstrate that different molecular mechanisms contribute to a gradual development of fluconazole resistance in C. albicans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was not until serial isolates taken from HIV-infected patients with oropharyngeal candidiasis were analysed for ERG11 and MDR1 mRNA expression levels that a link was established between the MDR1 gene and fluconazole resistance.98”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [98]
In the citing paper
“The overexpression of ERG11 had been shown to contribute to decreased azole susceptibility through increased production of the azole target 14α-lanosterol demethylase (Figure 1a).78 , 98 , 106 , 107”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,695
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 880
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465
Sanglard, D., Ischer, F., Monod, M., & Billé, J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2300 · Cited by 402
Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351
Self-citationKelly, S. L., Lamb, D. C., Corran, A. J., Baldwin, B. C., & Kelly, D. E. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1272 · Cited by 296
Self-citationWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1488 · Cited by 292
Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance
Albertson, G. D., Niimi, M., Cannon, R. D., & Jenkinson, H. F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2835 · Cited by 260
Molecular mechanisms of drug resistance in fungi
BOSSCHE, H. V., Marichal, P., & Odds, F. C. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90618-1 · Cited by 255
Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E., & Trautmann, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.9.2092-2098.1994 · Cited by 250
Self-citationKatzmann, D. J., Hallstrom, T. C., Voet, M., Wysock, W., Golin, J. E., Volckaert, G., & Moye-Rowley, S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6875 · Cited by 217
Transcriptional control of the yeast PDR5 gene by the PDR3 gene product.
Katzmann, D. J., Burnett, P. E., Golin, J. E., Mahé, Y., & Moye-Rowley, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4653 · Cited by 216
Fling, M. E., Kopf, J., Tamarkin, A., Gorman, J. A., Smith, H. A., & Koltin, Y. (1991) · Molecular and General Genetics MGG · doi:10.1007/bf00259685 · Cited by 205
Millon, L., Manteaux, A., Reboux, G., Drobacheff, C., Monod, M., Barale, T., & Michel-Briand, Y. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.1115-1118.1994 · Cited by 205
Lamb, D. C., Kelly, D. E., Schunck, W., Shyadehi, A. Z., Akhtar, M., Lowe, D. J., Baldwin, B. C., & Kelly, S. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5682 · Cited by 192
Self-citationKöhler, G. A., White, T. C., & Agabian, N. M. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.7.2331-2338.1997 · Cited by 191
Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains
Löffler, J., Kelly, S. L., Hebart, H. F., Schumacher, U., Lass‐Flörl, C., & Einsele, H. (1997) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1997.tb12580.x · Cited by 159
Self-citationGhannoum, M. A., Rex, J. H., & Galgiani, J. N. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.3.489-495.1996 · Cited by 159
Lockhart, S. R., Reed, B. D., Pierson, C. L., & Soll, D. R. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.4.767-777.1996 · Cited by 144
Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients
Kelly, S. L., Lamb, D. C., Kelly, D. E., Loeffler, J., & Einsele, H. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65949-1 · Cited by 140
Self-citationMolecular analysis of cyp51 from fluconazole-resistant Candida albicans strains
Löffler, J. (1997) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(97)00172-9 · Cited by 119
Nourani, A., Wésolowski‐Louvel, M., Delaveau, T., Jacq, C., & Delahodde, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5453 · Cited by 117
Mahé, Y., Parle‐McDermott, A., Nourani, A., Delahodde, A., Lamprecht, A., & Kuchler, K. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02493.x · Cited by 117
Nucleotide sequence of cytochrome P450 LIAI (lanosterol 14α-demethylase) fromCandida albicans
LAI, M. H., & Kirsch, D. R. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.2.804 · Cited by 106
Molecular genetic analysis of azole antifungal mode of action
Kelly, S. L., Arnoldi, A., & Kelly, D. E. (1993) · Biochemical Society Transactions · doi:10.1042/bst0211034 · Cited by 106
Self-citationSequence of theCandida albicansgene encoding actin
Losberger, C., & Ernst, J. F. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.22.9488 · Cited by 93
Multidrug resistance in Candida albicans: disruption of the BENr gene
Goldway, M., Teff, D., Schmidt, R., Oppenheim, A., & Koltin, Y. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.422 · Cited by 89
Schröppel, K., Rotman, M., Galask, R. P., Mac, K., & Soll, D. R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.11.2646-2654.1994 · Cited by 78
Venkateswarlu, K., Denning, D. W., Manning, N. J., & Kelly, S. L. (1995) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1995.tb07797.x · Cited by 67
Self-citationIsolation, characterization, and sequencing of Candida albicans repetitive element 2
Lasker, B. A., Page, L. S., Lott, T. J., & Kobayashi, G. S. (1992) · Gene · doi:10.1016/0378-1119(92)90628-3 · Cited by 66
Transcriptional Control of the Yeast PDR5 Gene by the PDR3 Gene Product
Katzmann, D. J., Burnett, P. E., Golin, J. E., Mahé, Y., & Moye-Rowley, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4653-4661.1994 · Cited by 51
Differential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers
Lamb, D. C., Kelly, D. E., Baldwin, B. C., Gozzo, F., Boscott, P. E., Richards, W. G., & Kelly, S. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1997.tb10303.x · Cited by 36
Self-citationCompletion of the IS map in E. coli: IS186 positions on the E. coli K12 chromosome
Birkenbihl, R. P., & Vielmetter, W. (1991) · Molecular and General Genetics MGG · doi:10.1007/bf00273620 · Cited by 33
Research works printed but not linked: 2
- Ausubel F. M. Brent R. Kingston R. E. Moore D. D. Seidman J. G. Smith J. A. Struhl K. Current protocols in molecular biology. 1989 John Wiley & Sons Inc. New York N.Y
- Odds F. C. Candida and candidosis: a review and bibliography. 1988 Bailliere Tindall London United Kingdom
Cited by
Sorted by citations
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Fluconazole resistance in Candida species: a current perspective
Berkow, E., & Lockhart, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s118892 · Cited by 542
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 531
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470
Metadata
- Authors
- Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., & Morschhäuser, J.
- Affiliations
- University of Würzburg (DE)
- Aberystwyth University (GB)
- Humboldt-Universität zu Berlin (DE)
- <!--label omitted: 1-->Zentrum für Infektionsforschung, Universität Würzburg, D-97070 Würzburg,1 and
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1998-12
- Volume
- 42
- Issue
- 12
- Pages
- 3065-3072
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC106000
- OpenAlex
- W2160765565
- Cited by
- 339
- References
- 38
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 4 · 2021: 11 · 2020: 14 · 2019: 15 · 2018: 8 · 2017: 14 · 2016: 11 · 2015: 10 · 2014: 16 · 2013: 12 · 2012: 7
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida albicans, fluconazole resistance, oropharyngeal candidiasis, AIDS, MDR1 gene, ERG11, sterol 14α-demethylase, major facilitator superfamily, drug accumulation, microevolution, recurrent infections, antifungal resistance mechanisms
- MeSH terms
- Alleles, Antifungal Agents, Candida albicans, Candidiasis, Cytochrome P-450 Enzyme System, Drug Resistance, Microbial, Gene Expression Regulation, Humans, Gas Chromatography-Mass Spectrometry, Microbial Sensitivity Tests, Nucleic Acid Hybridization, Oxidoreductases, RNA, Bacterial, Blotting, Southern, Blotting, Northern, Fluconazole, AIDS-Related Opportunistic Infections, Genes, MDR, Sterol 14-Demethylase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
